Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT-Reference-Cited by-同舟云学术

Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT

Published:2013-06-25 Issue:6 Volume:8 Page:e67052
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Banugaria Suhrad G.,Prater Sean N.,Patel Trusha T.,DeArmey Stephanie M.,Milleson Christie,Sheets Kathryn B.,Bali Deeksha S.,Rehder Catherine W.,Raiman Julian A. J.,Wang Raymond A.,Labarthe Francois,Charrow Joel,Harmatz Paul,Chakraborty Pranesh,Rosenberg Amy S.,Kishnani Priya S.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease);HG Hers;Biochem J,1963

2. Hirschhorn R, Reuser AJJ, editors (2009) Glycogen storage disease type II: acid a-glucosidase (acid maltase) deficiency New York: McGraw-Hill.

3. Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease;M Nicolino;Genet Med,2009

4. Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease;PS Kishnani;Neurology,2007

5. Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease;PS Kishnani;J Pediatr,2006

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing clinical outcomes: The journey of twins with CRIM-negative infantile-onset Pompe disease on high-dose enzyme replacement therapy and immunomodulation;Molecular Genetics and Metabolism Reports;2024-12

2. Mutation Spectrum of GAA Gene in Pompe Disease: Current Knowledge and Results of an Italian Study;International Journal of Molecular Sciences;2024-08-23

3. Optimizing treatment outcomes: immune tolerance induction in Pompe disease patients undergoing enzyme replacement therapy;Frontiers in Immunology;2024-04-23

4. Preclinical studies with ground germinated barley (GGB) for oral enzyme replacement therapy (Oral-ERT) in Pompe disease knockout mice;2023-12-28

5. Phase I study of liver depot gene therapy in late-onset Pompe disease;Molecular Therapy;2023-07